Brief: Lisata Therapeutics Receives $2.2 Million Of Non-Dilutive Capital Through New Jersey Technology Business Tax Certificate Transfer Program
20/04/2023 13:35
April 20 (Reuters) - Lisata Therapeutics Inc LSTA.O :
* LISATA THERAPEUTICS RECEIVES $2.2 MILLION OF NON-DILUTIVE
CAPITAL THROUGH NEW JERSEY TECHNOLOGY BUSINESS TAX CERTIFICATE
TRANSFER PROGRAM
Source text for Eikon: ID:nGNX4dRbFY
Further company coverage: LSTA.O
Recent news on Lisata Therapeutics
See all newsBrief: Lisata Therapeutics - Amends Merger Offer Price To $4 Per Share Plus CVR
Brief: Lisata Therapeutics Enters Into Definitive Agreement To Be Acquired By Kuva Labs, Inc.
U.S. STOCKS ON THE MOVE-Oklo, AMD, Lam Research
U.S. STOCKS ON THE MOVE-Aligos, Intel, Travelers Companies
Lisata jumps as Kuva Labs strikes acquisition deal